Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2013 on February 12
HAYWARD, Calif.--(BUSINESS WIRE)--
Aradigm Corporation (OTCBB:ARDM) (the "Company") today announced that
President and Chief Executive Officer, Igor Gonda, Ph.D., will present
at the 15th Annual BIO CEO & Investor Conference 2013 on
Tuesday, February 12, 2013, at 2:00 p.m. ET. The event will be held at
the Waldorf-Astoria Hotel in New York, New York.
Interested parties can access a live audio webcast and slide
presentation at www.aradigm.com.
An archived presentation will be available on the Company's Web site for
14 days.
About Aradigm
Aradigm is an emerging specialty pharmaceutical company focused on the
development and commercialization of a portfolio of drugs delivered by
inhalation for the treatment of severe respiratory diseases by
pulmonologists. The Company has product candidates addressing the
treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and
anthrax infections, and smoking cessation.
More information about Aradigm can be found at www.aradigm.com.
Aradigm and the Aradigm Logo are registered trademarks of Aradigm
Corporation.
Aradigm Corporation
Nancy Pecota, 510-265-8800
Chief Financial
Officer
Source: Aradigm Corporation
News Provided by Acquire Media
Print page
Email page
Download PDF
